The World Health Organization (WHO) welcomes the initial clinical trial
results from the United Kingdom (UK) that show dexamethasone, a
corticosteroid, can be lifesaving for patients who are critically ill
with COVID-19. For patients on ventilators, the treatment was shown to
reduce mortality by about one third, and for patients requiring only
oxygen, mortality was cut by about one fifth, according to preliminary
findings shared with WHO.
Read more at:
WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients
Read more at:
WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients
